Description
This product utilizes engineered Tregs that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone FH6R22-22). We employs the Lentivirus (CMV-GFP-IL-17-EcoRI) vector components and the SynExpress system of the single base pair Knock-in/Delayed feedback for a robust and sustained response against cancers.
Host
Human
Target
CD22
Clone
FH6R22-22
Species Reactivity
Human
Cell Source
Engineered Tregs
Sensor Gene
GFP
Promoter
CMV
Effector Gene
IL-17
Insertion Sites
EcoRI
Gene Modification
Knock-in
Modification Domain
Single base pair
Carrier Type
Lentivirus
Transformation Accuracy
0.93
Cell Culture
Adherent Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.